Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-06 Paulson Richard A. President and CEO Sale −4,012 $1.59 $6K 821,453
2024-01-24 Cheng Sohanya Roshan EVP & Chief Commercial Officer Grant or award +14,167 221,499
2024-01-24 Rangwala Reshma EVP & Chief Medical Officer Grant or award +14,167 172,397
2024-01-24 Poulton Stuart EVP, Chief Development Officer Grant or award +13,333 169,619
2024-01-24 Mano Michael SVP, General Counsel&Secretary Grant or award +9,167 151,401
2024-01-24 Mason Michael EVP, CFO & Treasurer Grant or award +13,333 251,150
2024-01-24 Paulson Richard A. President and CEO Grant or award +42,000 825,465
2024-01-04 Paulson Richard A. President and CEO Sale −4,114 $0.82 $3K 783,465
2023-12-04 Paulson Richard A. President and CEO Sale −3,622 $0.79 $3K 787,579
2023-11-06 Paulson Richard A. President and CEO Sale −3,606 $0.92 $3K 791,201
2023-10-04 Paulson Richard A. President and CEO Sale −3,589 $1.27 $5K 794,807
2023-09-12 BOHLIN GAREN G Director Purchase +41,140 $1.22 $50K 45,140
2023-09-05 Paulson Richard A. President and CEO Sale −3,558 $1.33 $5K 798,460
2023-09-05 Paulson Richard A. President and CEO Sale −64 $1.32 $84 798,396
2023-09-01 Mason Michael EVP, CFO & Treasurer Sale −6,913 $1.33 $9K 237,817
2023-09-01 Mano Michael SVP, General Counsel&Secretary Sale −3,888 $1.33 $5K 142,234
2023-09-01 Cheng Sohanya Roshan EVP & Chief Commercial Officer Sale −7,415 $1.33 $10K 204,086
2023-08-31 Su Zhen Director Grant or award · Nonstatutory Stock Option (right to buy) +68,000 68,000
2023-08-07 Paulson Richard A. President and CEO Sale 10b5-1 −3,722 $1.72 $6K 802,018
2023-07-28 Poulton Stuart EVP, Chief Development Officer Sale 10b5-1 −2,845 $1.70 $5K 156,286

Page 9 of 15 · 287 trades